These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment. Van Woensel JB; Kimpen JL; Brand PL Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731 [TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus infection in infants and young children. Levy BT; Graber MA J Fam Pract; 1997 Dec; 45(6):473-81. PubMed ID: 9420581 [TBL] [Abstract][Full Text] [Related]
5. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions. Cooper AC; Banasiak NC; Allen PJ Pediatr Nurs; 2003; 29(6):452-6. PubMed ID: 14743842 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infection and the primary care physician. Park JW; Barnett DW South Med J; 2002 Mar; 95(3):353-7. PubMed ID: 11902705 [TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Wendt CH; Hertz MI Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850 [TBL] [Abstract][Full Text] [Related]
9. Basic epidemiology and immunopathology of RSV in children. Handforth J; Friedland JS; Sharland M Paediatr Respir Rev; 2000 Sep; 1(3):210-4. PubMed ID: 12531081 [TBL] [Abstract][Full Text] [Related]
10. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile? Hashmi NA; Cosgrove JF; MacMahon P Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917 [TBL] [Abstract][Full Text] [Related]
11. Immunopathology of RSV infection: prospects for developing vaccines without this complication. van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293 [TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus in infants and children. Schwartz R Nurse Pract; 1995 Sep; 20(9):24-9. PubMed ID: 7501313 [TBL] [Abstract][Full Text] [Related]
13. [Respiratory syncytial virus: as an etiological agent of respiratory tract infection in children and adults]. Belino-Studzińska P; Pancer K Przegl Epidemiol; 2008; 62(4):767-75. PubMed ID: 19209739 [TBL] [Abstract][Full Text] [Related]
14. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [TBL] [Abstract][Full Text] [Related]
19. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA; Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [TBL] [Abstract][Full Text] [Related]